apl180
Peptideexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2006 (NCT00751608)
Timeline
Indications
Mechanism of action
- Apolipoprotein A-IINHIBITOR
APOA1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- apl180
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00907998 | Phase 1 | Jun 1, 2009 | Novartis |
| NCT00568594 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2007 | Novartis |
| NCT00751608 | Phase 2 | Sep 1, 2006 | Novartis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 3 | 3 | 2 | 2006 |
1 organizations
Page 1 / 1